Evidence map›Paper›PMID 37925436›Full record

ArticleNature communications2023

Systemic and intrinsic functions of ATRX in glial cell fate and CNS myelination in male mice.

Megan E Rowland, Yan Jiang, Sarfraz Shafiq, Alireza Ghahramani, Miguel A Pena-Ortiz, Vanessa Dumeaux, Nathalie G Bérubé

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Altered Brain Structure in an ATRX-Deficient Mouse Model of Autism Spectrum Disorder.Autism research : official journal of the International Society for Autism Research · 2026
    Article
  3. Article
  4. ATRX safeguards cellular identity duringbioRxiv : the preprint server for biology · 2026
    Article
  5. ATRX: From Chromatin Remodeling to Disease.Genesis (New York, N.Y. : 2000) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor-Suppressive Therapeutic Responses.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Megan E RowlandDepartment of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Yan JiangChildren's Health Research Institute, Division of Genetics & Development, London, ON, Canada.
Sarfraz ShafiqChildren's Health Research Institute, Division of Genetics & Development, London, ON, Canada.
Alireza GhahramaniChildren's Health Research Institute, Division of Genetics & Development, London, ON, Canada.
Miguel A Pena-OrtizChildren's Health Research Institute, Division of Genetics & Development, London, ON, Canada.
Vanessa DumeauxDepartment of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Nathalie G BérubéChildren's Health Research Institute, Division of Genetics & Development, London, ON, Canada. nberube@uwo.ca.
Children’s Health Research Institute · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelin, an extension of the oligodendrocyte plasma membrane, wraps around axons to facilitate nerve conduction. Myelination is compromised in ATR-X intellectual disability syndrome patients, but the causes are unknown. We show that loss of ATRX leads to myelination deficits in male mice that are partially rectified upon systemic thyroxine administration. Targeted ATRX inactivation in either neurons or oligodendrocyte progenitor cells (OPCs) reveals OPC-intrinsic effects on myelination. OPCs lacking ATRX fail to differentiate along the oligodendrocyte lineage and acquire a more plastic state that favors astrocytic differentiation in vitro and in vivo. ATRX chromatin occupancy in OPCs greatly overlaps with that of the chromatin remodelers CHD7 and CHD8 as well as H3K27Ac, a mark of active enhancers. Overall, our data indicate that ATRX regulates the onset of myelination systemically via thyroxine, and by promoting OPC differentiation and suppressing astrogliogenesis. These functions of ATRX identified in mice could explain white matter pathogenesis observed in ATR-X syndrome patients.

Indexed as

Myelin SheathThyroxineX-linked Nuclear Proteinalpha-ThalassemiaAnimalsCell DifferentiationChromatinHumansMaleMiceNeurogenesisNeurogliaOligodendrogliaX-Linked Intellectual DisabilityAtrx protein, mouseChromatinThyroxineX-linked Nuclear Protein

Identifiers

PMID37925436
PMCPMC10625541
OpenAlexW4388341798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.